MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(11 sites)

China

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

The Central Hospital of Huanggang, Huanggang, Hubei

The First People's Hospital of Jingzhou, Jingzhou, Hubei

Jingzhou Central Hospital, Jingzhou, Hubei

Shiyan Taihe Hospital, Shiyan, Hubei

Zhongnan Hospital of Wuhan University, Wuhan, Hubei

Xianning Central Hospital, Xianning, Hubei

The Central Hospital of Xiaogan, Xiaogan, Hubei

Yichang Central Hospital, Yichang, Hubei

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Wuxi, Jiangsu

Shanxi Cancer Hospital, Taiyuan, Shanxi